Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Major
Day Range133.80 | 136.59
52-Wk Range121.00 | 148.99
Last Close132.84
Mkt Cap (m)350,586.75
Dividend yield2.79%
ISINUS4781601046
Volume8,481,146
Exchange VenueNYS

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Key Information
Price/Earning22.03
Price/Book5.77
Price/Sales4.43
P/CF16.38
Rev Growth (3 year avg)5.20
EPS Growth (3 year avg)0.01
Operating Margin % 24.58
Net Margin %18.75
Return on Equity25.51
Debt/Equity0.51

Legal Documents

Prospectus
en 09/11/2017
Annual Report
en 30/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)71,31274,33170,07471,89076,45081,581
Operating Income (m)18,37720,95918,06521,13618,71420,049
Net Income (m)13,83116,32315,40916,5401,30015,297
Basic EPS4.925.805.566.040.485.70
Avg. Diluted Shares Outstanding (m)2,8772,8642,8132,7892,7452,729
Balance Sheet
USD201320142015201620172018
Current Assets (m)56,40759,31160,21065,03243,08846,033
Non Current Assets (m)76,27671,80873,20176,176114,215106,921
Total Assets (m)132,683131,119133,411141,208157,303152,954
Current Liabilities (m)25,67525,08527,74726,28730,53731,230
Total Liabilities (m)------
Total Equity (m)74,05369,75271,15070,41860,16059,752
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)17,41418,47119,27918,76721,05622,201
Capital Expenditure (m)-3,595-3,714-3,463-3,226-3,279-3,670
Figures are quoted in USD unless stated otherwise
2.54 (1.91%)
$
135.38
Last Price